Free Trial

Puma Biotechnology (PBYI) News Today

Puma Biotechnology logo
$3.21 +0.13 (+4.22%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$3.20 0.00 (-0.16%)
As of 05/2/2025 04:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Puma Biotechnology, Inc. stock logo
Zacks Research Issues Pessimistic Forecast for PBYI Earnings
Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Zacks Research cut their Q2 2025 earnings per share estimates for Puma Biotechnology in a report issued on Wednesday, April 30th. Zacks Research analyst R. Department now expects that the biopharmaceutical company will post earnings of $0.08
Puma Biotechnology, Inc. stock logo
Acorn Capital Advisors LLC Purchases Shares of 2,450,711 Puma Biotechnology, Inc. (NASDAQ:PBYI)
Acorn Capital Advisors LLC acquired a new stake in Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 2,450,711 shares of the biopharmaceutical company's stock, valued
Puma Biotechnology, Inc. stock logo
JPMorgan Chase & Co. Increases Stock Position in Puma Biotechnology, Inc. (NASDAQ:PBYI)
JPMorgan Chase & Co. increased its stake in Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) by 182.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 136,897 shares of the biopharmaceutical company's stock after purcha
Zacks Research Brokers Reduce Earnings Estimates for PBYI
Puma Biotechnology, Inc. stock logo
Q1 EPS Forecast for Puma Biotechnology Boosted by Analyst
Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Zacks Research increased their Q1 2026 earnings per share (EPS) estimates for Puma Biotechnology in a report released on Wednesday, April 30th. Zacks Research analyst R. Department now anticipates that the biopharmaceutical company will post
Q1 EPS Forecast for Puma Biotechnology Raised by Analyst
Puma Biotechnology, Inc. stock logo
Puma Biotechnology (NASDAQ:PBYI) Upgraded to Strong-Buy at StockNews.com
StockNews.com upgraded Puma Biotechnology from a "buy" rating to a "strong-buy" rating in a report on Friday.
Puma Biotechnology, Inc. stock logo
Puma Biotechnology (PBYI) to Release Quarterly Earnings on Thursday
Puma Biotechnology (NASDAQ:PBYI) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-puma-biotechnology-inc-stock/)
Puma Biotechnology, Inc. stock logo
Eversept Partners LP Decreases Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI)
Eversept Partners LP cut its stake in Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) by 23.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 996,102 shares of the biopharmaceutical company's sto
Puma Biotechnology, Inc. stock logo
Puma Biotechnology (NASDAQ:PBYI) Upgraded to "Strong-Buy" at StockNews.com
StockNews.com raised shares of Puma Biotechnology from a "buy" rating to a "strong-buy" rating in a report on Wednesday.
Puma Biotechnology, Inc. stock logo
Kennedy Capital Management LLC Buys 216,329 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI)
Kennedy Capital Management LLC boosted its position in shares of Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) by 36.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 809,375 shares of the biopharmaceutical compan
Puma Biotechnology, Inc. stock logo
WINTON GROUP Ltd Sells 270,739 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI)
WINTON GROUP Ltd decreased its position in Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) by 87.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 38,241 shares of the biopharmaceutical company's stock after sell
Puma SE: Undervalued With Tailwinds Ahead
PUMA SE: This Is The Right Time To Buy
Puma Biotechnology, Inc. stock logo
Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Purchased by Connor Clark & Lunn Investment Management Ltd.
Connor Clark & Lunn Investment Management Ltd. grew its position in shares of Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) by 32.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 487,368 shares
Puma Biotechnology, Inc. stock logo
Puma Biotechnology (NASDAQ:PBYI) Stock Crosses Above Two Hundred Day Moving Average - Here's What Happened
Puma Biotechnology (NASDAQ:PBYI) Shares Pass Above Two Hundred Day Moving Average - Should You Sell?
Puma Biotechnology, Inc. stock logo
Puma Biotechnology (NASDAQ:PBYI) Stock Rating Lowered by StockNews.com
StockNews.com lowered shares of Puma Biotechnology from a "strong-buy" rating to a "buy" rating in a report on Saturday.
Zooming In On Puma Biotechnology's Earnings
Puma Biotechnology, Inc. stock logo
Puma Biotechnology (NASDAQ:PBYI) Receives "Buy" Rating from HC Wainwright
HC Wainwright reaffirmed a "buy" rating and issued a $7.00 price objective on shares of Puma Biotechnology in a research note on Friday.
Puma Biotechnology, Inc. stock logo
Puma Biotechnology (NASDAQ:PBYI) Posts Earnings Results, Beats Expectations By $0.29 EPS
Puma Biotechnology (NASDAQ:PBYI - Get Free Report) announced its quarterly earnings results on Thursday. The biopharmaceutical company reported $0.39 earnings per share for the quarter, beating analysts' consensus estimates of $0.10 by $0.29. Puma Biotechnology had a net margin of 9.56% and a return on equity of 41.60%.
Puma Biotechnology sees FY25 product revenue $192M-$198M
Puma Biotechnology sees Q1 product revenue $41M-$43M
Puma Biotechnology, Inc. stock logo
Puma Biotechnology (PBYI) Projected to Post Quarterly Earnings on Thursday
Puma Biotechnology (NASDAQ:PBYI) will be releasing earnings after the market closes on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=335006)
Puma Biotechnology, Inc. stock logo
Zacks Research Analysts Increase Earnings Estimates for PBYI
Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Equities research analysts at Zacks Research lifted their FY2025 EPS estimates for Puma Biotechnology in a research note issued to investors on Wednesday, January 22nd. Zacks Research analyst R. Department now forecasts that the biopharmaceut
Puma Biotechnology, Inc. stock logo
Q4 EPS Estimate for Puma Biotechnology Boosted by Analyst
Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Investment analysts at Zacks Research lifted their Q4 2025 earnings per share estimates for Puma Biotechnology in a research report issued to clients and investors on Wednesday, January 22nd. Zacks Research analyst R. Department now forecasts
Get Puma Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for PBYI and its competitors with MarketBeat's FREE daily newsletter.

PBYI Media Mentions By Week

PBYI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PBYI
News Sentiment

0.30

0.73

Average
Medical
News Sentiment

PBYI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PBYI Articles
This Week

15

2

PBYI Articles
Average Week

Get Puma Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for PBYI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:PBYI) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners